NCT07347925 Effect of Pre-Hospital ARNI Therapy on Short-Term Outcomes in HFrEF
| NCT ID | NCT07347925 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Future University in Egypt |
| Condition | Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 140 participants |
| Start Date | 2026-01-10 |
| Primary Completion | 2026-04-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 140 participants in total. It began in 2026-01-10 with a primary completion date of 2026-04-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study looks at people with heart failure who are admitted to the hospital. The goal of the study is to understand whether taking a heart failure medicine called angiotensin receptor-neprilysin inhibitor (ARNI) before hospital admission affects short-term health outcomes. The study will compare two groups of participants: those who were already taking ARNI before coming to the hospital and those who were not. Information will be collected from medical records during the hospital stay, including heart-related events, kidney-related events, and how long participants stay in the hospital. Some participants will also be followed for a short period after discharge. This study may help improve understanding of outcomes associated with ARNI use in people with heart failure in routine clinical care.
Eligibility Criteria
Inclusion Criteria: * \>= 18 years, male or female EF \<40% Exclusion Criteria: * EF\>40% Pregnancy or breastfeeding
Frequently Asked Questions
Who can join the NCT07347925 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07347925 currently recruiting?
Yes, NCT07347925 is actively recruiting participants. Visit ClinicalTrials.gov or contact Future University in Egypt to inquire about joining.
Where is the NCT07347925 trial being conducted?
This trial is being conducted at Al Mansurah, Egypt.
Who is sponsoring the NCT07347925 clinical trial?
NCT07347925 is sponsored by Future University in Egypt. The trial plans to enroll 140 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.